Pulmicort suspension 0.25mg / ml, No. 20
Expiration Date: 05/2027
Russian Pharmacy name:
Пульмикорт суспензия 0,25мг/мл, №20
bronchial asthma, requiring maintenance therapy with corticosteroids;
chronic obstructive pulmonary disease (COPD);
stenosing laryngotracheitis (false croup).
Inhalation The dose of the drug is selected individually. If the recommended dose does not exceed 1 mg / day, the entire dose of the drug can be taken at one time (at a time). In case of taking a higher dose, it is recommended to divide it into 2 doses.
Recommended starting dose
Children 6 months and older - 0.25-0.5 mg / day. If necessary, the dose can be increased to 1 mg / day.
Adults / elderly patients - 1-2 mg / day.
Maintenance dose
Children 6 months and older - 0.25-2 mg / day.
Adults - 0.5-4 mg / day. In case of severe exacerbations, the dose may be increased.
Dose determination table
| Dose, mg | The volume of the drug PulmicortЃ, suspension for inhalation | |
| 0.25 mg / ml budesonide | 0.5 mg / ml budesonide | |
| 0.25 | 1 ml * | ? |
| 0.5 | 2 ml | ? |
| 0.75 | 3 ml | ? |
| one | 4 ml | 2 ml |
| 1.5 | ? | 3 ml |
| 2 | ? | 4 ml |
* Should be diluted with 0.9% sodium chloride solution to a volume of 2 ml.
For all patients, it is desirable to determine the minimum effective maintenance dose.
If it is necessary to achieve an additional therapeutic effect, it is possible to recommend an increase in the daily dose of PulmicortЃ (up to 1 mg / day) instead of a combination of the drug with oral corticosteroids, due to the lower risk of developing systemic effects.
Patients receiving oral corticosteroids
Cancellation of oral corticosteroids should be started against the background of a stable state of health of the patient. Within 10 days, it is necessary to take a high dose of PulmicortЃ while taking oral corticosteroids in the usual dose. Subsequently, within 1 month, the dose of oral corticosteroids (for example, 2.5 mg of prednisolone or its analogue) should be gradually reduced to the minimum effective dose. In many cases, it is possible to completely abandon the intake of oral corticosteroids.
Since PulmicortЃ, administered as a suspension with a nebulizer, enters the lungs during inhalation, it is important to instruct the patient to inhale the drug through the mouthpiece of the nebulizer calmly and evenly.
There is no data on the use of budesonide in patients with renal insufficiency or with impaired liver function. Taking into account the fact that budesonide is excreted by biotransformation in the liver, an increase in the duration of the drug's action in patients with severe liver cirrhosis can be expected.
Stenosing laryngotracheitis (false croup)
Children 6 months and older - 2 mg / day. The dose of the drug can be taken 1 time (at a time) or divided into 2 doses of 1 mg with an interval of 30 minutes.
| Suspension for inhalation metered | 1 ml |
| active substance: | |
| budesonide (micronized) | 0.25 mg |
| 0.5 mg | |
| excipients: sodium chloride - 8.5 mg; sodium citrate - 0.5 mg; disodium edetate (sodium salt of ethylenediaminetetraacetic acid disubstituted, disodium salt of EDTA) - 0.1 mg; polysorbate 80 - 0.2 mg; citric acid (anhydrous) - 0.28 mg; purified water - up to 1 ml |
hypersensitivity to budesonide;
children's age up to 6 months.
With caution (more careful monitoring of patients is required): in patients with active form of pulmonary tuberculosis; fungal, viral, bacterial infections of the respiratory system, cirrhosis of the liver; when prescribing, the possible manifestation of the systemic action of GCS should be taken into account.